Synaptic Transmission Steps

Why This Matters

Synaptic transmission is the foundation of everything your brain does. Every thought, emotion, memory, and movement depends on neurons successfully passing signals to one another. For this course, you need to understand more than just the sequence of events. You need to know how electrical signals convert to chemical signals, what triggers neurotransmitter release, and how the postsynaptic neuron integrates information. These concepts come up repeatedly in questions about drug mechanisms, neural plasticity, and psychiatric disorders.

Drugs work by hijacking specific steps in this process. SSRIs block reuptake. Botox prevents vesicle fusion. Benzodiazepines enhance receptor activity. If you understand where in the transmission sequence each step occurs and why it matters, you can predict how any drug affects neural communication. Don't just memorize the order. Know what molecular mechanism each step demonstrates and where pharmacological intervention can occur.

---

Signal Arrival: The Electrical Phase

The transmission process begins with purely electrical events. The action potential is the trigger that starts the whole cascade. If it doesn't reach the terminal, nothing else happens.

Action Potential Reaches Presynaptic Terminal

• Electrical signal propagation: the action potential travels down the axon via sequential depolarization until it reaches the axon terminal
• The all-or-nothing principle applies here; the signal arrives at full strength regardless of distance traveled
• Terminal depolarization is the critical trigger that activates voltage-sensitive proteins embedded in the presynaptic membrane

Voltage-Gated Calcium Channels Open

• These depolarization-sensitive channels respond specifically to the membrane potential change caused by the arriving action potential
• $Ca^{2+}$ channels are distinct from the $Na^+$ channels involved in action potential propagation. This specificity matters for drug targeting
• Electrical-to-chemical conversion begins here; this is the pivotal transition point in synaptic transmission

---

Release Machinery: The Secretion Phase

Calcium entry sets off a molecular cascade that physically moves neurotransmitters from storage vesicles into the synaptic cleft. This phase converts the electrical code into a chemical message through exocytosis.

Calcium Influx into Presynaptic Terminal

• Concentration gradient drives entry: extracellular $Ca^{2+}$ concentration is roughly 10,000 times higher than intracellular, so ions rush in when channels open
• Calcium acts as a second messenger, binding to sensor proteins that activate the fusion machinery
• Local concentration matters: $Ca^{2+}$ levels spike dramatically near the open channels, creating microdomains that activate only nearby vesicles

Synaptic Vesicles Fuse with Presynaptic Membrane

This step has specific molecular players you should know by name:

• SNARE proteins (v-SNAREs on vesicles, t-SNAREs on the target membrane) zipper together to pull the two membranes into contact
• Synaptotagmin is the calcium sensor on the vesicle. When $Ca^{2+}$ binds to it, synaptotagmin triggers the final fusion event
• Botulinum toxin cleaves SNARE proteins, preventing fusion entirely. That's why it paralyzes muscles: no fusion means no acetylcholine release at the neuromuscular junction

Neurotransmitters Released into Synaptic Cleft

• Exocytosis releases the entire contents of fused vesicles into the cleft simultaneously
• Quantal release: neurotransmitters are released in discrete packets (quanta), not as a continuous stream. Each vesicle is one quantum
• Diffusion across the cleft takes only microseconds because the gap is extremely narrow (approximately 20-40 nanometers)

---

Reception: The Postsynaptic Response Phase

Once neurotransmitters cross the cleft, the postsynaptic neuron must detect and interpret the chemical signal. Receptor binding translates the chemical message back into electrical changes in the receiving neuron.

Neurotransmitters Bind to Postsynaptic Receptors

• Lock-and-key specificity: each neurotransmitter fits particular receptor subtypes. Dopamine won't activate serotonin receptors because the binding site shape doesn't match
• Receptor density and affinity determine signal strength. More receptors or tighter binding means a stronger postsynaptic response
• Agonist drugs mimic neurotransmitters at this step by binding and activating receptors, while antagonists occupy the binding site without activating the receptor, effectively blocking it

Ion Channels Open or Close on Postsynaptic Membrane

Two major receptor types produce effects at very different speeds:

• Ionotropic receptors are ligand-gated ion channels that open directly when the neurotransmitter binds. They produce fast transmission on the order of milliseconds. AMPA and NMDA glutamate receptors are classic examples
• Metabotropic receptors use G-proteins to trigger intracellular signaling cascades that indirectly affect ion channels. They're slower but produce longer-lasting effects, sometimes modifying gene expression
• Ion selectivity determines whether the effect is excitatory or inhibitory: $Na^+$ or $Ca^{2+}$ influx depolarizes (excites), while $Cl^-$ influx or $K^+$ efflux hyperpolarizes (inhibits)

Postsynaptic Potential Generated (EPSP or IPSP)

• EPSPs (excitatory postsynaptic potentials) depolarize the membrane toward threshold, increasing the probability of firing
• IPSPs (inhibitory postsynaptic potentials) hyperpolarize the membrane away from threshold, decreasing the probability of firing
• Summation is key. A single synapse rarely triggers an action potential on its own. The postsynaptic neuron integrates thousands of EPSPs and IPSPs, both across space (spatial summation) and over time (temporal summation), to determine whether to fire

---

Termination: The Reset Phase

Transmission must end for the system to reset and respond to new signals. Without termination mechanisms, neurotransmitters would continuously activate receptors, causing overstimulation or receptor desensitization.

Neurotransmitter Reuptake or Degradation

• Reuptake transporters pump neurotransmitters back into the presynaptic terminal for recycling. SSRIs block the serotonin transporter (SERT); cocaine blocks the dopamine transporter (DAT)
• Enzymatic degradation breaks down neurotransmitters directly in the cleft. Acetylcholinesterase (AChE) destroys acetylcholine; monoamine oxidase (MAO) breaks down dopamine, serotonin, and norepinephrine
• The dominant termination method varies by neurotransmitter. Acetylcholine relies mainly on enzymatic degradation. Dopamine and serotonin rely mainly on reuptake. This is why different drug classes target different termination mechanisms

Synaptic Vesicle Recycling

• Endocytosis retrieves the vesicle membrane from the presynaptic surface after fusion
• Vesicle refilling requires specific vesicular transporters that pack neurotransmitters back into recycled vesicles
• Recycling rate limits sustained transmission. During high-frequency firing, vesicle depletion can cause synaptic fatigue, a temporary reduction in transmission strength

---

Quick Reference Table

---

Self-Check Questions

1. Which two steps involve calcium, and what different roles does $Ca^{2+}$ play in each?

2. A drug blocks voltage-gated calcium channels at the presynaptic terminal. Which subsequent steps in transmission would be affected, and why?

3. Compare and contrast how SSRIs and MAO inhibitors both increase monoamine signaling. What step does each target, and how do their mechanisms differ?

4. If a neuron receives simultaneous input producing 5 EPSPs and 3 IPSPs, what determines whether it fires an action potential?

5. Botulinum toxin and curare both cause paralysis, but they target different steps in transmission. Identify which step each affects and explain why both produce similar symptoms despite different mechanisms.